Citation: Ss. Hegde et Kf. Friday, DOPAMINE-BETA-HYDROXYLASE INHIBITION - A NOVEL SYMPATHO-MODULATORY APPROACH FOR THE TREATMENT OF CONGESTIVE-HEART-FAILURE, Current pharmaceutical design, 4(6), 1998, pp. 469-479
Authors:
SHETTY SG
BONHAUS D
LOURY D
EGLEN RM
HEGDE SS
WATSON N
Citation: Sg. Shetty et al., CHARACTERIZATION OF PD102807, A SELECTIVE M-4 MUSCARINIC RECEPTOR ANTAGONIST - RADIOLIGAND BINDING AND FUNCTIONAL-STUDIES, The FASEB journal, 12(4), 1998, pp. 819-819
Authors:
CHOPPIN A
CHAN Q
WATSON N
LOURY D
HEGDE SS
EGLEN RM
Citation: A. Choppin et al., EFFECT OF OVARIECTOMIZATION ON MUSCARINIC RECEPTORS IN THE RAT URINARY-BLADDER, The FASEB journal, 12(4), 1998, pp. 820-820
Citation: Ss. Hegde et al., THE NOVEL DOPAMINE-BETA-HYDROXYLASE INHIBITOR, NEPICASTAT AND ITS METABOLITE PROVIDE ANTIOXIDATIVE PROTECTION TO POSTISCHEMIC HEARTS OF MG-RESTRICTED RATS, The FASEB journal, 12(4), 1998, pp. 1476-1476
Authors:
MELOY TD
DANIELS DV
HEGDE SS
EGLEN RM
FORD APDW
Citation: Td. Meloy et al., FUNCTIONAL-CHARACTERIZATION OF MUSCARINIC CHOLINOCEPTORS IN RAT SUBMAXILLARY-GLAND (RSG) USING MICROPHYSIOMETRY, The FASEB journal, 12(4), 1998, pp. 2563-2563
Authors:
HEGDE SS
KUMAR AR
GANESH KN
SWAMINATHAN CP
KHAN MI
Citation: Ss. Hegde et al., THERMODYNAMICS OF LIGAND (SUBSTRATE END-PRODUCT) BINDING TO ENDOXYLANASE FROM CHAINIA SP. (NCL-82-5-1) - ISOTHERMAL CALORIMETRY AND FLUORESCENCE TITRATION STUDIES, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1388(1), 1998, pp. 93-100
Authors:
STANLEY WC
LEE KH
JOHNSON LG
WHITING RL
EGLEN RM
HEGDE SS
Citation: Wc. Stanley et al., CARDIOVASCULAR EFFECTS OF NEPICASTAT (RS-25560-197), A NOVEL DOPAMINE-BETA-HYDROXYLASE INHIBITOR, Journal of cardiovascular pharmacology, 31(6), 1998, pp. 963-970
Citation: Ss. Hegde et al., DO M-3 MUSCARINIC RECEPTORS MEDIATE CONTRACTION OF DOG CILIARY SMOOTH-MUSCLE - STUDIES WITH DARIFENACIN, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 526-526
Authors:
EGLEN RM
WATSON N
CHAN Q
BAILON R
CHOPPIN A
LOURY DN
BONHAUS DW
HEGDE SS
Citation: Rm. Eglen et al., INFLUENCE OF AGE AND OVARIECTOMY ON MUSCARINIC RECEPTORS IN RAT ISOLATED URINARY-BLADDER, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 527-527
Authors:
MELOY TD
DANIELS DV
HEGDE SS
EGLEN RM
FORD APDW
Citation: Td. Meloy et al., PHARMACOLOGY OF MUSCARINIC CHOLINOCEPTORS (MACHR) IN RAT SUBMAXILLARY-GLAND (RSG) USING MICROPHYSIOMETRY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 528-528
Authors:
HEGDE SS
SEIDEL SA
LADIPO JK
BRADSHAW LA
HALTER S
RICHARDS WO
Citation: Ss. Hegde et al., EFFECTS OF MESENTERIC ISCHEMIA AND REPERFUSION ON SMALL-BOWEL ELECTRICAL-ACTIVITY, The Journal of surgical research, 74(1), 1998, pp. 86-95
Authors:
HEGDE SS
MANDEL DA
WILFORD MR
BRIAND S
FORD APDW
EGLEN RM
Citation: Ss. Hegde et al., EVIDENCE FOR PURINERGIC NEUROTRANSMISSION IN THE URINARY-BLADDER OF PITHED RATS, European journal of pharmacology, 349(1), 1998, pp. 75-82
Authors:
GOUSSEV A
SHAROV VG
TANIMURA M
MISHIMA T
HEGDE SS
GOLDSTEIN S
SABBAH HN
Citation: A. Goussev et al., THERAPY WITH NEPICASTAT ATTENUATES REPLACEMENT FIBROSIS AND MYOCYTE HYPERTROPHY AND IMPROVES CAPILLARY DENSITY AND OXYGEN DIFFUSION DISTANCE IN MYOCARDIUM OF DOGS WITH HEART-FAILURE, Circulation, 98(17), 1998, pp. 534-534
Citation: A. Choppin et al., PHARMACOLOGICAL CHARACTERIZATION OF MUSCARINIC RECEPTORS IN RABBIT ISOLATED IRIS SPHINCTER MUSCLE AND URINARY-BLADDER SMOOTH-MUSCLE, British Journal of Pharmacology, 124(5), 1998, pp. 883-888
Authors:
WATSON N
DANIELS DV
FORD APDW
EGLEN RM
HEGDE SS
Citation: N. Watson et al., COMPARATIVE PHARMACOLOGY OF HUMAN MUSCARINIC M3 AND M5 CHOLINO-CEPTORS EXPRESSED IN CHINESE-HAMSTER OVARY (CHO) CELLS, British Journal of Pharmacology, 123, 1998, pp. 268-268
Citation: A. Choppin et al., MUSCARINIC M(2) RECEPTORS MODULATE RELAXANT RESPONSES TO ISOPROTERENOL IN RAT URINARY-BLADDER, Life sciences, 60(13-14), 1997, pp. 62-62
Authors:
SABBAH HN
TANIMURA M
MISHIMA T
BENEDICT CR
HEGDE SS
GOLDSTEIN S
Citation: Hn. Sabbah et al., EFFECTS OF LONG-TERM THERAPY WITH NEPICASTAT (RS-25560-197), A DOPAMINE-BETA-HYDROXYLASE INHIBITOR, ON LEFT-VENTRICULAR FUNCTION AND REMODELING IN DOGS WITH MODERATE HEART-FAILURE, Circulation, 96(8), 1997, pp. 508-508
Citation: A. Choppin et al., CHARACTERIZATION OF MUSCARINIC RECEPTORS IN THE RABBIT IRIS SPHINCTERMUSCLE, British Journal of Pharmacology, 122, 1997, pp. 51-51
Authors:
STANLEY WC
LI B
BONHAUS DW
JOHNSON LG
LEE K
PORTER S
WALKER K
MARTINEZ G
EGLEN RM
WHITING RL
HEGDE SS
Citation: Wc. Stanley et al., CATECHOLAMINE MODULATORY EFFECTS OF NEPICASTAT (RS-25560-197), A NOVEL, POTENT AND SELECTIVE INHIBITOR OF DOPAMINE-BETA-HYDROXYLASE, British Journal of Pharmacology, 121(8), 1997, pp. 1803-1809
Authors:
EGLEN RM
BONHAUS DW
CALIXTO JJ
CHOPPIN A
LEUNG E
LOEB M
LOURY D
MOY T
WILDA M
HEGDE SS
Citation: Rm. Eglen et al., CHARACTERIZATION OF THE INTERACTION OF TOLTERODINE AT MUSCARINIC RECEPTOR SUBTYPES IN-VITRO AND IN-VIVO, British Journal of Pharmacology, 120, 1997, pp. 63-63
Authors:
WHITING RL
STANLEY WC
BONHAUS D
JOHNSON LG
LEE K
PORTER S
WALKER K
EGLEN RM
HEGDE SS
Citation: Rl. Whiting et al., PHARMACOLOGY OF RS-25560-197, A NOVEL AND SELECTIVE INHIBITOR OF DOPAMINE-BETA-HYDROXILASE, British Journal of Pharmacology, 120, 1997, pp. 170-170